-
EpiPen Prescriptions Continue To Climb But Market Share Dropped
STAT | New data indicates prescriptions for the allergy emergency device are outpacing last year's figures. Overall, the number of prescriptions for EpiPen is up 14% through September, compared with the same period in 2015. In fact, there were 40% more prescriptions written in the first nine months of this year compared with 2013, even as the price for EpiPen was rising.
Oct 25, 2016
-
Dell Technologies Announces Availability of EMC Documentum for Life Sciences 4.2
Clinical Informatics News Brief | Dell Technologies Enterprise Content Division (ECD) announced the general availability of EMC Documentum for Life Sciences 4.2. The EMC Documentum for Life Sciences solution suite is designed to break down information silos to transform how organizations access, manage, and share regulated content.
Oct 24, 2016
-
UK Aims To Cut Four Years From Drug Development Process
Pharmaphorum | The UK government has published its long-awaited Accelerated Access Review, a report that aims to cut up to four years from the process that gets a drug from the lab to use on England's National Health Service.
Oct 24, 2016
-
FDA Official Warns Other Drug Makers Not to Copy Sarepta
STAT | An FDA official said this week that Sarepta's approach in winning approval for its DMD drug should not be copied by other drug firms.
Oct 21, 2016
-
Europe’s Drug Regulator Opens Vaults Of Clinical-Trials Data
Nature News & Comment | EMA becomes first major drugs agency to publish clinical study reports online.
Oct 20, 2016
-
New FDA/EMA Rare Diseases And Patient Engagement Clusters Underway
FDA Blog | The FDA has announced a new cluster with the EMA to advance treatments for patients with rare diseases.
Oct 18, 2016
-
FDA Awards 21 Grants To Stimulate Product Development For Rare Diseases
Clinical Informatics News Brief | The FDA announced yesterday that it has awarded 21 new clinical trial research grants totaling more than $23 million over the next four years to boost the development of products for patients with rare diseases.
Oct 18, 2016
-
The Fine Print of MACRA’s Final Rule: Good for Patients?
THCB | The Centers for Medicare & Medicaid Services (CMS) just released the final regulations for the most ambitious attempt in U.S. history to transform how medical care is delivered and paid for. But is it good for patients?
Oct 17, 2016
-
As Apple Watch tops Cleveland Clinic accuracy trial hints emerge about its future
MobiHealthNews | It's been a big couple of days for Apple's Apple Watch, which came out ahead in a small study published in the Journal of American Medical Association Cardiology journal yesterday. Additionally, news broke today of two patents that could predict some intriguing future features for the device, and Politico reported on a potential new healthcare use case with the device.
Oct 14, 2016
-
A Letter from CMS to Clinicians in the Quality Payment Program We Heard You and Will Continue Listening
THCB | Andy Slavitt writes that CMS has listened to clinician feedback in finalizing the implementation of MACRA. "The policy released today is the first step in a multi-year journey in which we are particularly focused on allowing clinicians to transition at their own pace," he says.
Oct 14, 2016
-
Veeva Systems Announces EDC, eSource, And Expansion Of Its Leadership Team
Clinical Informatics News Brief | Veeva announces EDC and eSource to improve the speed and quality of data to cut cost and complexity in clinical trials. Veeva has also expanded its leadership team across product management and cloud software development.
Oct 13, 2016
